Ekman Lars
Insider CIK 1376117 · ITMN Director · OCRX Director · RARE Director · PRTA Director · SPHS Director · ONCE Director · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2026-05-15 | 2026-05-15 | 27,000 | — | $0 | 27,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2025-05-14 | 2025-05-16 | 20,183 | — | $0 | 20,183 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2024-05-15 | 2024-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2023-05-17 | 2023-05-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,834 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 6,621 | $56.33 | $373.0K | 3,148 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 10 | $59.46 | $595 | 312 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 1,523 | $58.67 | $89.4K | 322 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 1,303 | $56.98 | $74.2K | 1,845 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 69 | $60.85 | $4.2K | 243 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 2,897 | $55.35 | $160.3K | 9,769 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2023-01-03 | 2023-01-05 | 3,411 | $54.15 | $184.7K | 12,666 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2023-01-03 | 2023-01-05 | 15,834 | $6.41 | $101.5K | 16,077 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-12-01 | 2022-12-02 | 15,834 | — | $0 | 15,834 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-12-01 | 2022-12-02 | 15,834 | $6.41 | $101.5K | 16,077 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-12-01 | 2022-12-02 | 9,813 | $61.28 | $601.3K | 6,264 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-12-01 | 2022-12-02 | 6,021 | $62.12 | $374.0K | 243 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-11-01 | 2022-11-03 | 15,833 | — | $0 | 31,668 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-01 | 2022-11-03 | 9,143 | $62.01 | $567.0K | 6,933 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-01 | 2022-11-03 | 3,312 | $64.26 | $212.8K | 1,904 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-01 | 2022-11-03 | 1,717 | $62.91 | $108.0K | 5,216 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-11-01 | 2022-11-03 | 1,661 | $64.94 | $107.9K | 243 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-11-01 | 2022-11-03 | 15,833 | $6.41 | $101.5K | 16,076 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-10-03 | 2022-10-05 | 15,833 | — | $0 | 47,501 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-03 | 2022-10-05 | 3,508 | $60.32 | $211.6K | 12,568 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-10-03 | 2022-10-05 | 15,833 | $6.41 | $101.5K | 16,076 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-03 | 2022-10-05 | 4,277 | $61.07 | $261.2K | 8,291 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-03 | 2022-10-05 | 1,693 | $62.96 | $106.6K | 243 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-10-03 | 2022-10-05 | 6,355 | $62.11 | $394.7K | 1,936 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise deriv | 2022-09-28 | 2022-09-30 | 31,666 | — | $0 | 63,334 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | S Sale | 2022-09-28 | 2022-09-30 | 31,666 | $48.09 | $1.52M | 243 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | M Exercise | 2022-09-28 | 2022-09-30 | 31,666 | $6.41 | $203.0K | 31,909 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2022-06-27 | 2022-06-29 | 93,750 | — | $0 | 93,750 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2022-06-27 | 2022-06-29 | 115,919 | — | $0 | 115,919 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-06-24 | 2022-06-28 | 6,245 | — | $0 | 6,245 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-06-24 | 2022-06-28 | 3,300 | — | $0 | 17,745 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2022-05-18 | 2022-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-06-24 | 2021-06-28 | 4,125 | — | $0 | 4,125 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-06-24 | 2021-06-28 | 2,145 | — | $0 | 14,445 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 38,000 | — | $0 | 38,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 48,506 | — | $0 | 48,506 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-05-19 | 2021-05-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 15,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 9,803 | — | $0 | 9,803 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 15,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 6,315 | — | $0 | 6,315 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | D To issuer deriv | 2021-02-12 | 2021-02-17 | 12,000 | — | $0 | 0 | SEC↗ |
| PRTA PROTHENA CORP PUBLIC LTD C | A Award deriv | 2021-02-12 | 2021-02-17 | 8,426 | — | $0 | 8,426 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 36,739 | — | $0 | 36,739 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 28,702 | — | $0 | 28,702 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-06-26 | 2020-06-30 | 4,250 | — | $0 | 4,250 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-06-26 | 2020-06-30 | 2,550 | — | $0 | 12,300 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2020-05-20 | 2020-05-22 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 37,203 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 6,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | D To issuer deriv | 2019-12-17 | 2019-12-17 | 4,000 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | U Tender | 2019-12-17 | 2019-12-17 | 3,000 | $114.50 | $343.5K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-11-12 | 2019-11-13 | 38,600 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-11-12 | 2019-11-13 | 38,600 | $19.35 | $746.9K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-11-12 | 2019-11-13 | 38,600 | $14.40 | $555.8K | 38,600 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-11-05 | 2019-11-07 | 6,400 | — | $0 | 38,600 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-11-05 | 2019-11-07 | 6,400 | $18.00 | $115.2K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-11-05 | 2019-11-07 | 6,400 | $14.40 | $92.2K | 6,400 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-09-03 | 2019-09-05 | 13,500 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-09-03 | 2019-09-05 | 25,845 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-09-03 | 2019-09-05 | 51,671 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-09-03 | 2019-09-05 | 91,016 | $15.01 | $1.37M | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-09-03 | 2019-09-05 | 13,500 | $5.58 | $75.3K | 13,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-09-03 | 2019-09-05 | 25,845 | $3.06 | $79.1K | 39,345 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-09-03 | 2019-09-05 | 51,671 | $3.21 | $165.9K | 91,016 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2019-06-27 | 2019-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-06-11 | 2019-06-13 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-06-11 | 2019-06-13 | 3,000 | — | $0 | 9,750 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2019-05-30 | 2019-06-03 | 1,500 | — | $0 | 3,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2019-05-22 | 2019-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 10,431 | — | $0 | 10,431 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 8,023 | — | $0 | 8,023 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 19,584 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 6,390 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 28,500 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 35,258 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 17,358 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-03-04 | 2019-03-06 | 28,287 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 28,287 | $2.50 | $70.7K | 135,377 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 17,358 | $2.50 | $43.4K | 107,090 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 35,258 | $2.19 | $77.2K | 89,732 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-03-04 | 2019-03-06 | 98,677 | $21.16 | $2.09M | 36,700 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-03-04 | 2019-03-06 | 36,700 | $21.71 | $796.8K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 28,500 | $1.87 | $53.3K | 54,474 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 6,390 | $1.87 | $11.9K | 25,974 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-03-04 | 2019-03-06 | 19,584 | $1.03 | $20.2K | 19,584 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 100,416 | — | $0 | 19,584 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 48,711 | $17.29 | $842.2K | 63,258 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 55,762 | $18.16 | $1.01M | 7,496 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 7,496 | $18.62 | $139.6K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 100,416 | $1.03 | $103.4K | 140,416 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 21,200 | $14.92 | $316.3K | 119,216 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 7,247 | $15.96 | $115.7K | 111,969 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2018-06-27 | 2018-06-28 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-06-19 | 2018-06-20 | 5,000 | — | $0 | 5,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-06-19 | 2018-06-20 | 3,000 | — | $0 | 6,750 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise deriv | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 0 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | M Exercise | 2018-05-31 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 1,500 | — | $0 | 1,500 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2018-05-30 | 2018-05-31 | 4,000 | — | $0 | 4,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2018-05-16 | 2018-05-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 34,269 | — | $0 | 34,269 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 51,671 | — | $0 | 51,671 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-06-22 | 2017-06-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-06-22 | 2017-06-22 | 1,875 | — | $0 | 3,750 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2017-05-31 | 2017-06-02 | 1,500 | — | $0 | 1,500 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2017-05-30 | 2017-06-01 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2017-05-18 | 2017-05-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 25,845 | — | $0 | 25,845 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 17,974 | — | $0 | 17,974 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 25,115 | — | $0 | 25,115 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 35,258 | — | $0 | 35,258 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-09 | 2016-06-14 | 3,750 | — | $0 | 3,750 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-09 | 2016-06-14 | 1,875 | — | $0 | 1,875 | SEC↗ |
| ONCE Spark Therapeutics, Inc. | A Award deriv | 2016-06-01 | 2016-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2016-05-27 | 2016-05-31 | 8,250 | — | $0 | 8,250 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-03-17 | 2016-03-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise deriv | 2015-11-25 | 2015-11-25 | 30,000 | — | $0 | 95,000 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-11-25 | 2015-11-25 | 16,588 | $72.96 | $1.21M | 13,655 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-11-25 | 2015-11-25 | 11,502 | $73.73 | $848.0K | 2,153 | SEC↗ |
| PRTA Prothena Corp plc | M Exercise | 2015-11-25 | 2015-11-25 | 30,000 | $6.41 | $192.3K | 30,243 | SEC↗ |
| PRTA Prothena Corp plc | S Sale | 2015-11-25 | 2015-11-25 | 1,910 | $74.43 | $142.2K | 243 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 22,000 | — | $0 | 22,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 28,287 | — | $0 | 28,287 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 40,500 | — | $0 | 40,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 17,358 | — | $0 | 17,358 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2015-05-27 | 2015-05-28 | 8,250 | — | $0 | 8,250 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2015-05-22 | 2015-05-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | S Sale | 2014-12-18 | 2015-01-23 | 9,663 | $0.47 | $4.5K | 520 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 15,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 8,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 45,003 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 4,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | U Tender | 2014-09-29 | 2014-10-01 | 5,500 | $74.00 | $407.0K | 0 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2014-06-17 | 2014-06-18 | 8,250 | — | $0 | 8,250 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2014-06-11 | 2014-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 5,500 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 5,348 | — | $0 | 5,348 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 6,390 | — | $0 | 6,390 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2013-11-20 | 2013-11-20 | 40,000 | $1.80 | $72.0K | 40,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | A Award deriv | 2013-10-25 | 2013-10-29 | 16,500 | — | $0 | 16,500 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-08-30 | 2013-12-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 11,969 | — | $0 | 11,969 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | A Award deriv | 2013-07-15 | 2013-07-17 | 2,992 | — | $0 | 2,992 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 13,500 | — | $0 | 13,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PRTA Prothena Corp plc | A Award deriv | 2013-01-29 | 2013-01-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2012-07-10 | 2012-07-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2012-06-04 | 2012-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2012-06-04 | 2012-06-06 | 2,500 | $10.10 | $25.3K | 2,500 | SEC↗ |